SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Schrodinger, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$23.12+0.52 (+2.30%)
Close on Oct 19, 2026
- Market cap
- $1.75B
- P/E (TTM)
- –
- Dividend yield
- –
Schrodinger, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software | $181.17M | $186.24M | $199.50M | $209.88M | $200.91M | $195.77M | $180.37M | $169.36M | $166.38M | $160.33M | $159.12M | $138.29M | 69.9% | -9.8% |
| Drug Discovery | $77.87M | $68.66M | $56.37M | $47.07M | $37.01M | $34.73M | $27.17M | $23.99M | $34.25M | $28.16M | $57.54M | $61.10M | 30.1% | +110.4% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software products and services | $178.24M | $181.73M | $199.50M | $201.52M | $192.55M | $191.92M | $180.37M | $169.36M | $166.38M | $160.33M | $159.12M | $138.29M | 68.8% | -7.4% |
| On-premise software | $83.76M | $90.21M | $101.45M | $112.49M | $108.81M | $111.82M | $104.02M | $102.57M | $104.13M | $102.19M | $104.51M | $84.19M | 32.3% | -23.0% |
| Drug discovery | $77.28M | $68.24M | $56.37M | $46.30M | $36.24M | $34.23M | $27.17M | $23.99M | $34.25M | $28.16M | $57.54M | $61.10M | 29.8% | +113.3% |
| Hosted software | $50.35M | $46.33M | $45.12M | $44.76M | $41.99M | $38.95M | $35.25M | $30.09M | $26.74M | $23.11M | $20.38M | $18.49M | 19.4% | +19.9% |
| Software maintenance | $25.26M | $27.16M | $27.29M | $26.29M | $25.12M | $24.18M | $23.28M | $23.08M | $23.18M | $23.21M | $23.07M | $22.63M | 9.8% | +0.6% |
| Professional services | $11.24M | $10.41M | $9.65M | $8.17M | $8.62M | $8.95M | $9.80M | $10.49M | $10.53M | $10.02M | $9.37M | $11.17M | 4.3% | +30.5% |
| Software contribution | – | – | $54.76M | $45.32M | $35.12M | $32.69M | $25.14M | – | – | – | – | – | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $158.18M | $154.71M | $152.96M | $131.30M | $124.59M | $121.24M | $114.87M | $133.14M | $141.65M | $134.91M | $161.96M | $146.14M | 61.1% | +27.0% |
| APAC | $73.07M | $72.25M | $75.16M | $97.87M | $87.29M | $82.44M | $65.65M | $34.77M | $33.38M | $29.50M | $29.14M | $27.18M | 28.2% | -16.3% |
| EMEA | $26.51M | $26.78M | $26.18M | $26.11M | $24.64M | $25.47M | $25.80M | $24.28M | $24.57M | $23.00M | $24.57M | $25.05M | 10.2% | +7.6% |
| Rest of World | $1.27M | $1.16M | $1.56M | $1.67M | $1.40M | $1.35M | $1.22M | $1.16M | $1.03M | $1.07M | $1.00M | $1.01M | 0.5% | -8.9% |
From the segment and revenue-disaggregation notes of Schrodinger's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.